Cargando…
Development of Thiophene Compounds as Potent Chemotherapies for the Treatment of Cutaneous Leishmaniasis Caused by Leishmania major
Leishmania major (L. major) is a protozoan parasite that causes cutaneous leishmaniasis. About 12 million people are currently infected with an annual incidence of 1.3 million cases. The purpose of this study was to synthesize a small library of novel thiophene derivatives, and evaluate its parasiti...
Autores principales: | Rodriguez, Felipe, Iniguez, Eva, Pena Contreras, Guadalupe, Ahmed, Haidar, Costa, Thadeu E. M. M., Skouta, Rachid, Maldonado, Rosa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100043/ https://www.ncbi.nlm.nih.gov/pubmed/29973498 http://dx.doi.org/10.3390/molecules23071626 |
Ejemplares similares
-
Thiophene derivatives activity against the protozoan parasite Leishmania infantum
por: Bigot, Sophia, et al.
Publicado: (2022) -
EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica
por: El Hajj, Rana, et al.
Publicado: (2018) -
An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major
por: Iniguez, Eva, et al.
Publicado: (2017) -
Histological and immunological differences between zoonotic cutaneous leishmaniasis due to Leishmania major and sporadic cutaneous leishmaniasis due to Leishmania infantum
por: Boussoffara, Thouraya, et al.
Publicado: (2019) -
Cutaneous sporotrichoid leishmaniasis: An atypical case caused by Leishmania major
por: Bassaid, Adila, et al.
Publicado: (2022)